drugset / Trial / NCT02661347
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Withdrawn
Northwell Health
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the efficacy of transcranial direct current stimulation (tDCS) for the treatment of auditory hallucinations in patients currently on risperidone treatment who are experiencing recent onset psychosis.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risperidone | Other / unclassified | 1 mg | — |
| Comparator | Risperidone | Other / unclassified | 6 mg | — |